Hospital systems often have a sole designated person responsible for maintaining compliance with new USP Chapter <797> regulations about sterile compounding, and for compliance with new USP <800> regulations about safe handling of hazardous drugs. This is true even though USP allows for multiple designated persons. This finding is among those in ASHP’s 2024 survey about sterile compounding in hospital settings, reported at the ASHP Midyear 2024 Clinical
FEBRUARY 7, 2025